Next Article in Journal
Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury
Next Article in Special Issue
Synthetic Inhibitors of Snake Venom Enzymes: Thioesters Derived from 2-Sulfenyl Ethylacetate
Previous Article in Journal
Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines
Previous Article in Special Issue
Hierarchical Virtual Screening of Potential Insectides Inhibitors of Acetylcholinesterase and Juvenile Hormone from Temephos
Open AccessArticle

Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring

Faculty of Pharmacy with Medical Analytics Division, Medical University of Lublin, Chodźki 4a, 20-093, Lublin, Poland
FQS-Fujitsu Poland, Parkowa 11, 33-332 Kraków, Poland
Institute of Applied Radiation Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Łódź, Poland
Author to whom correspondence should be addressed.
Pharmaceuticals 2019, 12(2), 64;
Received: 1 April 2019 / Revised: 19 April 2019 / Accepted: 20 April 2019 / Published: 24 April 2019
(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs)
In this study, 48 inhibitors were docked to 107 allosteric centers of human immunodeficiency virus 1 (HIV-1) reverse transcriptase from the Protein Data Bank (PDB). Based on the average binding scores, quantitative structure-activity relationship (QSAR) equations were constructed in order to elucidate directions of further development in the design of inhibitors. Such developments, informed by structural data, must have a focus on activity against mutated forms of the enzyme, which are the cause of the emergence of multidrug-resistant viral strains. Docking studies employed the HYDE scoring function. Two types of QSARs have been considered: One based on topological descriptors and the other on structural fragments of the inhibitors. Both methods gave similar results, indicating substructures favoring binding to mutated forms of the enzyme. View Full-Text
Keywords: HIV-1 reverse transcriptase; docking; HYDE; QSAR HIV-1 reverse transcriptase; docking; HYDE; QSAR
Show Figures

Figure 1

MDPI and ACS Style

Paneth, A.; Płonka, W.; Paneth, P. Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring. Pharmaceuticals 2019, 12, 64.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop